ArticlePharmaceuticals (Basel, Switzerland)2025

Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on "Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review.

Michalina Józwiak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.